Intratumoral Cancer Therapy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis

1.    Introduction

2.    Research Methodology
3.    Executive Summary

4.    Market Dynamics

4.1        Drivers
4.2        Restraints

5.    Global Intratumoral Cancer Therapy Market

6.    Market Share Analysis - Global Intratumoral Cancer Therapy Market

6.1    By Application
6.2    Technology Type
6.3    By End User
6.4    By Regions

7.    Application - Global Intratumoral Cancer Therapy Market

7.1    Lung Cancer
7.2    Breast Cancer
7.3    Colorectal Cancer
7.4    Melanoma
7.5    Prostate Cancer
7.6    Head & Neck Cancer
7.7    Others

8.    Technology Type - Global Intratumoral Cancer Therapy Market

8.1    Monoclonal Antibodies
8.2    Vaccines
8.3    Checkpoint Inhibitors
8.4    Cell Therapies
8.5    Immune System Modulators
8.6    Adoptive Cell Transfer
8.7    Cytokines
8.8    Others

9.    End Users - Global Intratumoral Cancer Therapy Market

9.1    Hospital
9.2    Cancer Research Centres
9.3    Clinica

10.    Regions - Global Intratumoral Cancer Therapy Market

10.1    North America
10.2    Europe
10.3    Asia Pacific
10.4    Latin America
10.5    Middle East & Africa

11.    Porters Five Forces

11.1    Overview
11.2    Bargaining Power of Buyers
11.3    Bargaining Power of Suppliers
11.4    Degree of Competition
11.5    Threat of New Entrants
11.6    Threat of Substitutes

12.    Company Analysis – Global Intratumoral Cancer Therapy Market

12.1    Amgen Inc.

12.1.1    Overview
12.1.2    Initiatives & Strategy
12.1.3    Revenue

12.2    AstraZeneca

12.2.1    Overview
12.2.2    Initiatives & Strategy
12.2.3    Revenue

12.3    Bayer AG

12.3.1    Overview
12.3.2    Initiatives & Strategy
12.3.3    Revenue

12.4    Bristol-Myers Squibb Comapny

12.4.1    Overview
12.4.2    Initiatives & Strategy
12.4.3    Revenue

12.5    Pfizer Inc

12.5.1    Overview
12.5.2    Initiatives & Strategy
12.5.3    Revenue

12.6    Novarts AG

12.6.1    Overview
12.6.2    Initiatives & Strategy
12.6.3    Revenue

12.7    Johnson & Johnson

12.7.1    Overview
12.7.2    Initiatives & Strategy
12.7.3    Revenue

12.8    Eli Lily Comapny

12.8.1    Overview
12.8.2    Initiatives & Strategy
12.8.3    Revenue

12.9    F. Hoffmann-la Roche Ltd

12.9.1    Overview
12.9.2    Initiatives & Strategy
12.9.3    Revenue

12.10    Seattle Genetics Inc

12.10.1    Overview
12.10.2    Initiatives & Strategy
12.10.3    Revenue

List Of Figures:

Figure-01:        Global – Intratumoral Cancer Therapy Market (Billion US$), 2017 – 2021
Figure-02:        Global – Forecast for Intratumoral Cancer Therapy Market (Billion US$), 2022 – 2027
Figure-03:        Application – Lung Cancer Market (Billion US$), 2017 – 2021
Figure-04:        Application – Forecast for Lung Cancer Market (Billion US$), 2022 – 2027
Figure-05:        Application – Breast Cancer Market (Billion US$), 2017 – 2021
Figure-06:        Application – Forecast for Breast Cancer Market (Billion US$), 2022 – 2027
Figure-07:        Application – Colorectal Cancer Market (Billion US$), 2017 – 2021
Figure-08:        Application – Forecast for Colorectal Cancer Market (Billion US$), 2022 – 2027
Figure-09:        Application – Melanoma Market (Billion US$), 2017 – 2021
Figure-10:        Application – Forecast for Melanoma Market (Billion US$), 2022 – 2027
Figure-11:        Application – Prostate Cancer Market (Billion US$), 2017 – 2021
Figure-12:        Application – Forecast for Prostate Cancer Market (Billion US$), 2022 – 2027
Figure-13:        Application – Head & Neck Cancer Market (Billion US$), 2017 – 2021
Figure-14:        Application – Forecast for Head & Neck Cancer Market (Billion US$), 2022 – 2027
Figure-15:        Application – Others Market (Billion US$), 2017 – 2021
Figure-16:        Application – Forecast for Others Market (Billion US$), 2022 – 2027
Figure-17:        Technology Type – Monoclonal Antibodies Market (Billion US$), 2017 – 2021
Figure-18:        Technology Type – Forecast for Monoclonal Antibodies Market (Billion US$), 2022 – 2027
Figure-19:        Technology Type – Vaccines Market (Billion US$), 2017 – 2021
Figure-20:        Technology Type – Forecast for Vaccines Market (Billion US$), 2022 – 2027
Figure-21:        Technology Type – Checkpoint Inhibitors Market (Billion US$), 2017 – 2021
Figure-22:        Technology Type – Forecast for Checkpoint Inhibitors Market (Billion US$), 2022 – 2027
Figure-23:        Technology Type – Cell Therapies Market (Billion US$), 2017 – 2021
Figure-24:        Technology Type – Forecast for Cell Therapies Market (Billion US$), 2022 – 2027
Figure-25:        Technology Type – Immune System Modulators Market (Billion US$), 2017 – 2021
Figure-26:        Technology Type – Forecast for Immune System Modulators Market (Billion US$), 2022 – 2027
Figure-27:        Technology Type – Adoptive Cell Transfer Market (Billion US$), 2017 – 2021
Figure-28:        Technology Type – Forecast for Adoptive Cell Transfer Market (Billion US$), 2022 – 2027
Figure-29:        Technology Type – Cytokines Market (Billion US$), 2017 – 2021
Figure-30:        Technology Type – Forecast for Cytokines Market (Billion US$), 2022 – 2027
Figure-31:        Technology Type – Others Market (Billion US$), 2017 – 2021
Figure-32:        Technology Type – Forecast for Others Market (Billion US$), 2022 – 2027
Figure-33:        End User – Hospital Market (Billion US$), 2017 – 2021
Figure-34:        End User – Forecast for Hospital Market (Billion US$), 2022 – 2027
Figure-35:        End User – Cancer Research Centres Market (Billion US$), 2017 – 2021
Figure-36:        End User – Forecast for Cancer Research Centres Market (Billion US$), 2022 – 2027
Figure-37:        End User – Clinical Market (Million US$), 2017 – 2021
Figure-38:        End User – Forecast for Clinical Market (Million US$), 2022 – 2027
Figure-39:        North America – Intratumoral Cancer Therapy Market (Billion US$), 2017 – 2021
Figure-40:        North America – Forecast for Intratumoral Cancer Therapy Market (Billion US$), 2022 – 2027
Figure-41:        Europe – Intratumoral Cancer Therapy Market (Million US$), 2017 – 2021
Figure-42:        Europe – Forecast for Intratumoral Cancer Therapy Market (Million US$), 2022 – 2027
Figure-43:        Asia Pacific – Intratumoral Cancer Therapy Market (Billion US$), 2017 – 2021
Figure-44:        Asia Pacific – Forecast for Intratumoral Cancer Therapy Market (Billion US$), 2022 – 2027
Figure-45:        Latin America – Intratumoral Cancer Therapy Market (Billion US$), 2017 – 2021
Figure-46:        Latin America – Forecast for Intratumoral Cancer Therapy Market (Billion US$), 2022 – 2027
Figure-47:        Middle East & Africa – Intratumoral Cancer Therapy Market (Million US$), 2017 – 2021
Figure-48:        Middle East & Africa – Forecast for Intratumoral Cancer Therapy Market (Million US$), 2022 – 2027
Figure-49:        Amgen Inc. – Global Revenue (Million US$), 2017 – 2021
Figure-50:        Amgen Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-51:        AstraZeneca – Global Revenue (Million US$), 2017 – 2021
Figure-52:        AstraZeneca – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-53:        Bayer AG – Global Revenue (Million US$), 2017 – 2021
Figure-54:        Bayer AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-55:        Bristol-Myers Squibb Comapny – Global Revenue (Million US$), 2017 – 2021
Figure-56:        Bristol-Myers Squibb Comapny – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-57:        Pfizer Inc – Global Revenue (Million US$), 2017 – 2021
Figure-58:        Pfizer Inc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-59:        Novarts AG – Global Revenue (Million US$), 2017 – 2021
Figure-60:        Novarts AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-61:        Johnson & Johnson – Global Revenue (Million US$), 2017 – 2021
Figure-62:        Johnson & Johnson – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-63:        Eli Lily Comapny – Global Revenue (Million US$), 2017 – 2021
Figure-64:        Eli Lily Comapny – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-65:        F. Hoffmann-la Roche Ltd – Global Revenue (Million US$), 2017 – 2021
Figure-66:        F. Hoffmann-la Roche Ltd – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-67:        Seattle Genetics Inc – Global Revenue (Million US$), 2017 – 2021
Figure-68:        Seattle Genetics Inc – Forecast for Global Revenue (Million US$), 2022 – 2027

List Of Tables:

Table-01:        Global – Intratumoral Cancer Therapy Market Share by Application (Percent), 2017 – 2021
Table-02:        Global – Forecast for Intratumoral Cancer Therapy Market Share by Application (Percent), 2022 – 2027
Table-03:        Global – Intratumoral Cancer Therapy Market Share by Technology Type (Percent), 2017 – 2021
Table-04:        Global – Forecast for Intratumoral Cancer Therapy Market Share by Technology Type (Percent), 2022 – 2027
Table-05:        Global – Intratumoral Cancer Therapy Market Share by End User (Percent), 2017 – 2021
Table-06:        Global – Forecast for Intratumoral Cancer Therapy Market Share by End User (Percent), 2022 – 2027
Table-07:        Global – Intratumoral Cancer Therapy Market Share by Region (Percent), 2017 – 2021
Table-08:        Global – Forecast for Intratumoral Cancer Therapy Market Share by Region (Percent), 2022 – 2027